CliffBio
small molecule

METOCLOPRAMIDE HYDROCHLORIDE

METOCLOPRAMIDE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyPar →See this company's full patent-cliff portfolio

Drug detail

Brand nameMETOCLOPRAMIDE HYDROCHLORIDE
Active ingredientMETOCLOPRAMIDE HYDROCHLORIDE
StrengthEQ 10MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMarch 1986
Marketing statusDISCN

More from Par

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

METOCLOPRAMIDE HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio